Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice
Authors:
- 8 July 2005
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (29) , 10297-10302
Abstract
Thyroid hormones [predominantly 3,5,3′-triiodo- l -thyronine (T 3 )] regulate cholesterol and lipoprotein metabolism, but cardiac effects restrict their use as hypolipidemic drugs. T 3 binds to thyroid hormone receptors (TRs) α and β. TRβ is the predominant isoform in liver, whereas T 3 effects on heart rate are mediated mostly by TRα. Drugs that target TRβ or exhibit tissue-selective uptake may improve plasma lipid levels while sparing the heart. Here, we asked how the TRβ- and liver uptake-selective agonist GC-1 influences cholesterol and triglyceride metabolism in euthyroid mice. GC-1 treatment reduced serum cholesterol levels by 25% and serum triglycerides by 75% in chow-fed mice and also attenuated diet-induced hypercholesterolemia. GC-1 reduced plasma high-density lipoprotein cholesterol levels; increased expression of the hepatic high-density lipoprotein receptor, SR-BI; stimulated activity of cholesterol 7α-hydroxylase; and increased fecal excretion of bile acids. Collectively, these results suggest that GC-1 stimulates important steps in reverse cholesterol transport. Use of TRβ and uptake selective agonists such as GC-1 should be further explored as a strategy to improve lipid metabolism in dyslipoproteinemia.Keywords
This publication has 71 references indexed in Scilit:
- European guidelines on cardiovascular disease prevention in clinical practiceAtherosclerosis, 2003
- Prolonged Stimulation of the Adrenals by Corticotropin Suppresses Hepatic Low-Density Lipoprotein and High-Density Lipoprotein Receptors and Increases Plasma CholesterolEndocrinology, 2002
- Growth hormone reduces plasma cholesterol in LDL receptor‐deficient miceThe FASEB Journal, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Feedback and Hormonal Regulation of Hepatic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase: The Concept of Cholesterol Buffering CapacityProceedings of the Society for Experimental Biology and Medicine, 2000
- The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and EClinical Endocrinology, 1997
- New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosisAtherosclerosis, 1996
- Effects of Bile Acids and Steroid/Thyroid Hormones on the Expression of Cholesterol 7α-Hydroxylase mRNA and the CYP7 Gene in HepG2 CellsBiochemical and Biophysical Research Communications, 1994
- Effect of thyroid hormone on hepatic cholesterol 7α hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized ratsBiochemical and Biophysical Research Communications, 1990
- Plasma triglyceride metabolism in thyroid diseaseJournal of Clinical Investigation, 1972